Le Lézard
Classified in: Business, Covid-19 virus
Subjects: NPT, ECO, SRI

New Price Index Identifies True Cost of Social Outcomes, Helps Philanthropy and Government Make Every Dollar Count


NEW YORK, Nov. 19, 2020 /PRNewswire/ -- As COVID-19 continues to inflict its toll, companies, governments, and individuals have stepped up their philanthropic investments to address the health, economic, and social fallout. Despite these efforts, one question persists in the minds of all types of donors: what does it really cost to make an impact on someone's life?  To date, the field has not had the ability to answer that question ? until now.

Launched today by The Conference Board in collaboration with the Impact Genome Project® and with support from Moody's, a new suite of benchmarking tools will enable companies, governments and individuals to evaluate and optimize their societal investments. The goal is to help donors produce more efficient and effective outcomes.

"With philanthropic and government spending at unsustainable levels, now more than ever, we need a way to rationalize our resources and maximize our 'bang for the buck' so that we can help as many people as possible," said Jason Saul, CEO of the Impact Genome Project®.        

Anchoring the digital hub is the Price of Impact (POI) Indextm. The tool, which was developed by the Impact Genome Project®, tracks how much it costs to solve problems in 100 different areas of social impact, including the arts, education, and the environment. Updated monthly, the POI Indextm uses inputs from thousands of US-based nonprofits and social programs to create cost-per-outcome averages. For instance, last month, the POI Indextm listed providing one person with a month of hunger relief at $533, compared to $66 for reducing one person's carbon footprint (such as increasing an individual's short-term likelihood to recycle or purchase solar panels).

The Conference Board's flagship report, Data-Driven Corporate Philanthropy: The Revolutionary Potential to Change Lives, was based on data from the POI Indextm. Findings from the report include the following:

Higher costs-per-outcome (CPO) often address issues that disproportionately affect minorities.

COVID-19's fallout will likely raise the cost of economic development outcomes ? which is already relatively high ? as the pandemic continues to increase demand for areas like job training and personal finance education.

COVID-19 could force companies to shift from focusing on long-term to short-term impacts, especially when it comes to education.

"In an era where corporations are on the front lines in addressing major societal issues, corporate philanthropy is one of the key tools at their disposal to have an impact.  As businesses give generously, they must also give wisely," said Paul Washington, Executive Director of the ESG Center of The Conference Board. "That is our purpose with this launch: to enable philanthropic dollars to do more. This is a transformative opportunity."

The hub also offers member-exclusive programming, including briefings from the Impact Genome Project®. Visit the Optimizing Societal Impact hub to explore all the latest reports, insights, and tools from The Conference Board.

About The Conference Board
The Conference Board is the member-driven think tank that delivers trusted insights for what's ahead. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States. www.conference-board.org

About The Impact Genome Project®
The Impact Genome Project® (IGP) is a field-wide, systematic effort to standardize measurement, reporting, and evidence for the world's most common social outcomes. The data and tools of the IGP enable funders, policymakers, and practitioners to allocate grant dollars based on impact, to design and implement effective interventions, to benchmark results, and to ultimately solve social problems more efficiently.

About Moody's
Moody's (NYSE:MCO) is a global risk assessment firm that empowers organizations to make better decisions. Its data, analytical solutions and insights help decision-makers identify opportunities and manage the risks of doing business with others. We believe that greater transparency, more informed decisions, and fair access to information open the door to shared progress. With over 11,400 employees in more than 40 countries, Moody's combines international presence with local expertise and over a century of experience in financial markets. Learn more at moodys.com/about.

Moody's builds toward a world where more people have access to opportunity, and where everyone has what they need to grow and thrive. We are committed to opening the door to brighter futures through our global corporate social responsibility programs connecting people around the world with the knowledge and resources they need to succeed. For more information visit moodys.com/csr.

SOURCE The Conference Board


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: